Celldex Therapeutics
CLDX
#4691
Rank
ยฃ1.47 B
Marketcap
ยฃ22.20
Share price
6.44%
Change (1 day)
6.10%
Change (1 year)

Celldex Therapeutics (CLDX) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ1.96 Million

According to Celldex Therapeutics's latest financial reports the company's total debt is ยฃ1.96 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Celldex Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ3.03 M52.28%
2023-12-31ยฃ1.99 M-40.15%
2022-12-31ยฃ3.33 M47.92%
2021-12-31ยฃ2.25 M-11.75%
2020-12-31ยฃ2.55 M-8.43%
2019-12-31ยฃ2.78 M
2018-12-31N/A-100%
2017-12-31ยฃ4.85 M
2015-12-31ยฃ2.98 M79.07%
2014-12-31ยฃ1.66 M
2013-12-31N/A-100%
2012-12-31ยฃ7.01 M-28%
2011-12-31ยฃ9.74 M39.04%
2010-12-31ยฃ7 M-18.06%
2009-12-31ยฃ8.55 M5649.97%
2008-12-31ยฃ0.14 M-94.28%
2007-12-31ยฃ2.6 M9.75%
2006-12-31ยฃ2.37 M95.8%
2005-12-31ยฃ1.21 M1146.04%
2004-12-31ยฃ0.09 M
2000-12-31ยฃ0.18 M-47.21%
1999-12-31ยฃ0.34 M-63.8%
1998-12-31ยฃ0.96 M-1.21%
1997-12-31ยฃ0.97 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Seagen
SGEN
ยฃ85.13 M 4,229.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ34.33 M 1,646.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.49 B 25,199.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ40.94 B 2,082,578.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ45.64 B 2,321,456.66%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ17.89 B 910,315.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA